DK97283D0 - Fremgangsmade til fremstilling af derivater af 1,2,4-triaziner og - pyridiner - Google Patents
Fremgangsmade til fremstilling af derivater af 1,2,4-triaziner og - pyridinerInfo
- Publication number
- DK97283D0 DK97283D0 DK0972/83A DK97283A DK97283D0 DK 97283 D0 DK97283 D0 DK 97283D0 DK 0972/83 A DK0972/83 A DK 0972/83A DK 97283 A DK97283 A DK 97283A DK 97283 D0 DK97283 D0 DK 97283D0
- Authority
- DK
- Denmark
- Prior art keywords
- triazines
- pyridines
- procedure
- preparing derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/16—Halogen atoms; Nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Luminescent Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/354,982 US4513135A (en) | 1982-03-05 | 1982-03-05 | Diaryl-pyrazine derivatives affecting GABA binding |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK97283D0 true DK97283D0 (da) | 1983-02-28 |
| DK97283A DK97283A (da) | 1983-09-06 |
Family
ID=23395746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97283A DK97283A (da) | 1982-03-05 | 1983-02-28 | Fremgangsmaade til fremstilling af derivater af 1,2,4-triaziner og -pyridiner |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US4513135A (da) |
| EP (1) | EP0088593B1 (da) |
| JP (1) | JPS58162582A (da) |
| KR (1) | KR860000847B1 (da) |
| AT (1) | ATE27457T1 (da) |
| AU (1) | AU547581B2 (da) |
| CA (1) | CA1195327A (da) |
| DD (1) | DD207716A5 (da) |
| DE (1) | DE3371786D1 (da) |
| DK (1) | DK97283A (da) |
| ES (2) | ES8404346A1 (da) |
| FI (1) | FI830708L (da) |
| GB (1) | GB2116179B (da) |
| GR (1) | GR78459B (da) |
| HU (1) | HU191368B (da) |
| IL (1) | IL68002A (da) |
| NZ (1) | NZ203428A (da) |
| PH (1) | PH22535A (da) |
| PL (1) | PL240871A1 (da) |
| PT (1) | PT76312B (da) |
| RO (1) | RO86320B (da) |
| ZA (1) | ZA831387B (da) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2567518B1 (fr) * | 1984-07-11 | 1987-11-13 | Sanofi Sa | Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent |
| JPH06501926A (ja) * | 1990-08-06 | 1994-03-03 | 藤沢薬品工業株式会社 | 複素環式化合物 |
| GB9420010D0 (en) * | 1994-10-01 | 1994-11-16 | Marck Sharp & Dohme Limited | Nucleic acids |
| EP0934061B3 (en) | 1996-07-24 | 2015-01-21 | Warner-Lambert Company LLC | Isobutylgaba and its derivatives for the treatment of pain |
| TWI316055B (da) * | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| KR100490893B1 (ko) * | 2002-10-11 | 2005-05-23 | (주) 비엔씨바이오팜 | 2-메톡시-1,3,5-트리아진 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물 |
| US20070003394A1 (en) * | 2005-02-01 | 2007-01-04 | Carey Paul G | Anti-cross threading fastener |
| EP1871762A2 (en) * | 2005-04-18 | 2008-01-02 | Neurogen Corporation | Subtituted heteroaryl cb1 antagonists |
| EP2275096A3 (en) | 2005-08-26 | 2011-07-13 | Braincells, Inc. | Neurogenesis via modulation of the muscarinic receptors |
| EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| WO2007047978A2 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| EP2314289A1 (en) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
| EP2021000A2 (en) | 2006-05-09 | 2009-02-11 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| ES2579949T3 (es) | 2010-02-05 | 2016-08-17 | Heptares Therapeutics Limited | Derivados de 1,2,4-triazin-4-amina |
| GB201106829D0 (en) | 2011-04-21 | 2011-06-01 | Proximagen Ltd | Heterocyclic compounds |
| TW201321353A (zh) * | 2011-10-08 | 2013-06-01 | Novartis Ag | 胺基甲酸酯／尿素衍生物 |
| IL311645B2 (en) * | 2016-07-12 | 2025-11-01 | Revolution Medicines Inc | 2,5- disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines asallosteric shp2 inhibitors |
| EP3549935A4 (en) * | 2016-11-30 | 2020-08-05 | Mitsubishi Tanabe Pharma Corporation | TRIAZINE COMPOUND PRODUCTION PROCESS |
| CA3051054A1 (en) | 2017-01-23 | 2018-07-26 | Revolution Medicines, Inc. | Pyridine compounds as allosteric shp2 inhibitors |
| CN110446709B (zh) | 2017-01-23 | 2023-09-12 | 锐新医药公司 | 作为变构shp2抑制剂的二环化合物 |
| TWI852912B (zh) | 2017-09-07 | 2024-08-21 | 美商銳新醫藥公司 | Shp2抑制劑組合物以及治療癌症的方法 |
| BR112020007058A2 (pt) | 2017-10-12 | 2020-10-06 | Revolution Medicines, Inc. | compostos de piridina, pirazina, e triazina como inibidores de shp2 alostéricos |
| BR112020009757A2 (pt) | 2017-12-15 | 2020-11-03 | Revolution Medicines, Inc. | compostos policíclicos como inibidores alostéricos de shp2 |
| EP3788050B1 (en) | 2018-05-01 | 2024-08-28 | Revolution Medicines, Inc. | C26-linked rapamycin analogs as mtor inhibitors |
| PL3788049T3 (pl) | 2018-05-01 | 2023-06-19 | Revolution Medicines, Inc. | Połączone z C40, C28 i C32 analogi rapamycyny jako inhibitory mTOR |
| EP4531859A4 (en) | 2022-05-25 | 2026-05-27 | Revolution Medicines Inc | CANCER TREATMENT METHODS USING AN MTOR INHIBITOR |
| CN117304174B (zh) * | 2022-06-20 | 2026-04-28 | 四川轻化工大学 | 一种5,6-二苯基吡嗪-2-氮杂环类化合物及其制备方法和应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3172889A (en) * | 1965-03-09 | Process for the separation of z-methyl- | ||
| US3294638A (en) * | 1961-06-05 | 1966-12-27 | Warner Lambert Pharmaceutical | Method and compositions employing 2-alkyl-3-piperidinopyrazines |
| CH480795A (de) * | 1967-03-01 | 1969-11-15 | Sandoz Ag | Mittel zur Beeinflussung des Pflanzenwachstums |
| US3989831A (en) * | 1974-01-31 | 1976-11-02 | Eli Lilly And Company | Topically-active anti-inflammatory 3-chloro-5,6-diaryl-1,2,4-triazines |
| US3979516A (en) * | 1974-01-31 | 1976-09-07 | Eli Lilly And Company | Anti-inflammatory 3-amino-5,6-diaryl-1,2,4-triazines |
| US4013654A (en) * | 1974-01-31 | 1977-03-22 | Eli Lilly And Company | 5,6-diaryl-1,2,4-triazines |
| US3948894A (en) * | 1974-01-31 | 1976-04-06 | Eli Lilly And Company | 3-Amino-5,6-diaryl-1,2,4-triazines |
| US4081542A (en) * | 1975-04-21 | 1978-03-28 | Merck & Co., Inc. | Piperazinylpyrazines |
| GB1493998A (en) * | 1975-06-03 | 1977-12-07 | Beecham Group Ltd | Propanolamine derivatives |
| US4008232A (en) * | 1975-06-23 | 1977-02-15 | Eli Lilly And Company | 3-Amino-5,6-diaryl-1,2,4-triazines |
| US4082844A (en) * | 1976-02-09 | 1978-04-04 | Merck & Co., Inc. | 6-chloro-2-(1-piperazinyl)pyrazine |
| US4018923A (en) * | 1976-03-10 | 1977-04-19 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents |
| US4021553A (en) * | 1976-03-10 | 1977-05-03 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents |
| US4190725A (en) * | 1976-03-10 | 1980-02-26 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines |
| NL7802514A (nl) * | 1977-03-09 | 1978-09-12 | Fabre Sa Pierre | 5,6-diaryl-1,2,4-triazinederivaten en werkwijze ter bereiding van deze verbindingen. |
| CH633541A5 (en) * | 1977-05-17 | 1982-12-15 | Diamond Shamrock Corp | Pharmacologically active substituted 1,2,4-triazines and medicaments containing these triazines |
| US4157392A (en) * | 1977-05-17 | 1979-06-05 | Diamond Shamrock Corporation | Pharmacologically active substituted 1,2,4-triazines |
| US4251527A (en) * | 1977-05-17 | 1981-02-17 | Diamond Shamrock Corporation | Pharmacologically active substituted 1,2,4-triazines |
-
1982
- 1982-03-05 US US06/354,982 patent/US4513135A/en not_active Expired - Fee Related
-
1983
- 1983-02-28 DK DK97283A patent/DK97283A/da not_active Application Discontinuation
- 1983-02-28 RO RO110181A patent/RO86320B/ro unknown
- 1983-02-28 IL IL68002A patent/IL68002A/xx unknown
- 1983-03-01 NZ NZ203428A patent/NZ203428A/en unknown
- 1983-03-01 PH PH28587A patent/PH22535A/en unknown
- 1983-03-01 PT PT76312A patent/PT76312B/pt unknown
- 1983-03-01 ZA ZA831387A patent/ZA831387B/xx unknown
- 1983-03-02 JP JP58035221A patent/JPS58162582A/ja active Pending
- 1983-03-02 KR KR1019830000833A patent/KR860000847B1/ko not_active Expired
- 1983-03-02 FI FI830708A patent/FI830708L/fi not_active Application Discontinuation
- 1983-03-03 GB GB08305846A patent/GB2116179B/en not_active Expired
- 1983-03-03 EP EP83301142A patent/EP0088593B1/en not_active Expired
- 1983-03-03 CA CA000422805A patent/CA1195327A/en not_active Expired
- 1983-03-03 DE DE8383301142T patent/DE3371786D1/de not_active Expired
- 1983-03-03 AU AU12029/83A patent/AU547581B2/en not_active Ceased
- 1983-03-03 AT AT83301142T patent/ATE27457T1/de not_active IP Right Cessation
- 1983-03-04 PL PL24087183A patent/PL240871A1/xx unknown
- 1983-03-04 HU HU83762A patent/HU191368B/hu unknown
- 1983-03-04 DD DD83248497A patent/DD207716A5/de unknown
- 1983-03-04 GR GR70688A patent/GR78459B/el unknown
- 1983-03-04 ES ES520340A patent/ES8404346A1/es not_active Expired
- 1983-10-06 ES ES526297A patent/ES8504173A1/es not_active Expired
-
1985
- 1985-01-04 US US06/688,946 patent/US4585861A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK97283A (da) | Fremgangsmaade til fremstilling af derivater af 1,2,4-triaziner og -pyridiner | |
| DK263481A (da) | Fremgangsmaade til fremstilling af substituerede tricycliske forbindelser | |
| DK283881A (da) | Fremgangsmaade til fremstilling af pyrazinyl1,2,4-oxadiazol-5-oner | |
| DK17983D0 (da) | Fremgangsmade til fremstilling af 6-substituerede s-triazol(3,4-a)-ftalazin-derivater | |
| ES542383A0 (es) | Procedimiento para la estabilizacion de pegamentos. | |
| ES8506657A1 (es) | Procedimiento para la preparacion de 3-(1-sustituido-4-piperidil)-1, 2-bencisoxazoles | |
| FI840463A0 (fi) | Vissa bensazokinon- och bensazoninonderivat | |
| DK156385C (da) | Apparat til portionspakning af langstrakte genstande, navnlig guleroedder | |
| DK433781A (da) | Fremgangsmaade til fremstilling af n-(2-pyrimidinyl) piperazinylalkylazespiroalkadioner | |
| BG45552A3 (bg) | Метод за получаване на 2-фенил-хексахидро-1,2,4- триазин-3,5-диони | |
| BG40803A3 (bg) | Метод за получаване на арилциклобутилалкиламинови производни | |
| BG40147A3 (bg) | Метод за получаване на хетероциклични съединения | |
| BG36935A3 (en) | Method for preparing benzodiazepine compounds | |
| DK42284A (da) | Fremgangsmaade til fraktionering af phosphatider | |
| BG35043A3 (en) | Method for preparing condensed asymmetric triazine derivatives | |
| ES8507530A1 (es) | Un procedimiento para la preparacion de aricoxicicloalcanolaminolaminoalquilen-aril-cetonas. | |
| DK454183A (da) | Fremgangsmaade til fremstilling af 15-cycloaliphatiske derivater af 13,14-didehydro-carboprostancycliner | |
| DK398882A (da) | Fremgangsmaade til fremstilling af hidtil ukendte antihypertensive forbindelser | |
| DK357883D0 (da) | Fremgangsmade til fremstilling af 3-hydroxy-1,2,4-triazol-derivater | |
| BG45852A3 (en) | Method for preparing of n- acyl- l- propyline derivatives | |
| DK0582977T3 (da) | Fremgangsmåde til fremstilling af 1,3-dialkyl-5-hydroxyoxindoler og etherderivater deraf | |
| DK93884D0 (da) | Fremgangsmade til fremstilling af 1,5-dibeskyttede-1,5,10-triazadecaner, mellemprodukter derfor samt disses fremstilling | |
| DK353783D0 (da) | Fremgangsmade til fremstilling af 0,s-dimethylthiolophosphorsyreamid | |
| DK361683D0 (da) | Fremgangsmade til fremstilling af 5-substituerede 3-amino-isoxazoler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |